[Treatment of essential hypertension with spironolactone with reference to the plasma renin activity].
D001794:Blood Pressure / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D002986:Clinical Trials as Topic; D007172:Erectile Dysfunction / Q000139:chemically induced; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D012083:Renin / Q000097:blood*; D013148:Spironolactone / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*
D013148:Spironolactone; D012083:Renin
Behandlung essentieller Hypertoniker mit Spirolakton unter Berücksichtigung der Plasma-Renin-Aktivität.